ION Breast Cancer Clinical Pathways - ION Solutions
ION Breast Cancer Clinical Pathways - ION Solutions
ION Breast Cancer Clinical Pathways - ION Solutions
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Clinical</strong> Trial:Screen patient for clinical trial. Check www.clinicaltrials.gov for available trials.Best Supportive Care and/or Hospice:Consider supportive care options and Hospice when appropriate.Note: Treatment for PS≥3 will be considered off pathway.Small Cell Lung: Limited DiseaseChemotherapy:Platinol (Cisplatin) VP-16 (Etoposide) XRT EP=HighCisplatin 60mg/m 2 D1Etoposide 120mg/m 2 D1-3ORCisplatin 80mg/m 2 D1Etoposide 100mg/m 2 D1-3XRTQ 21 Day Cycle>> N Engl J Med 340:265-271, 1999>> J Clin Oncol 24:5247-5252, 2006Paraplatin (Carboplatin) VP-16 (Etoposide) XRT EP=ModerateCarboplatin AUC 5-6 D1Etoposide 100mg/m 2 D1-3XRTq 21 Day Cycle>> Ann Oncol 12:1231-1238, 2001<strong>Clinical</strong> Trial:Screen patient for clinical trial. Check www.clinicaltrials.gov for available trials.Best Supportive Care and/or Hospice:Consider supportive care options and Hospice when appropriate.Page 30 of 39© 2013 by <strong>ION</strong> <strong>Solutions</strong>. All rights reserved
Change language